National Institute on Drug Abuse; Amended Notice of Meeting, 4928 [2011-1673]
Download as PDF
4928
Federal Register / Vol. 76, No. 18 / Thursday, January 27, 2011 / Notices
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel, Clinical Trials in Sepsis.
Date: February 18, 2011.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Room
3AN12B, Bethesda, MD 20892. (Telephone
Conference Call).
Contact Person: Brian R. Pike, PhD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN18, Bethesda, MD
20892. 301–594–3907. pikbr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: January 20, 2011.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–1684 Filed 1–26–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSKH9S0YB1PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Emerging
Technologies and Training Neurosciences
Integrated Review Group, Molecular
Neurogenetics Study Section.
Date: February 10, 2011.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Mar<15>2010
17:51 Jan 26, 2011
Jkt 223001
Place: Sheraton Delfina Hotel, 530 Pico
Boulevard, Santa Monica, CA 90405.
Contact Person: Paek-Gyu Lee, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5203,
MSC 7812, Bethesda, MD 20892. (301) 435–
0902. leepg@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR09–153:
Collaborative R01s in Molecular
Neurogenetics.
Date: February 10, 2011.
Time: 4 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Delfina Hotel, 530 Pico
Boulevard, Santa Monica, CA 90405.
Contact Person: Paek-Gyu Lee, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4201,
MSC 7812, Bethesda, MD 20892. (301) 435–
1277. leepg@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Chronic Diseases.
Date: February 16–18, 2011.
Time: 5 p.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting.)
Contact Person: Bob Weller, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3160,
MSC 7770, Bethesda, MD 20892. (301) 435–
0694. wellerr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflicts: Asthma, Lung Immunology, and
Lung Physiology.
Date: February 23, 2011.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call).
Contact Person: Everett E Sinnett, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2178,
MSC 7818, Bethesda, MD 20892. 301–435–
1016. sinnett@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Fellowships: Sensory, Motor, and Cognitive
Neuroscience.
Date: February 28–March 1, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Delfina Hotel, 530 Pico
Boulevard, Santa Monica, CA 90405.
Contact Person: Yuan Luo, PhD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5207 MSC 7846, Bethesda, MD
20892–7846. 301–827–7915.
luoy2@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 20, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–1681 Filed 1–26–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Advisory
Council on Drug Abuse, February 2,
2011, 8:30 a.m. to 2:45 p.m., National
Institutes of Health, Neuroscience
Center, 6001 Executive Boulevard,
Rockville, MD, 20852 which was
published in the Federal Register on
January 14, 2011, 76; 10 FR 2011–727.
The time of the closed session on
February 2, 2011 was changed to 8:30
a.m. to 10:15 a.m. and the time of the
open session was changed to 10:30 a.m.
to 2:45 p.m. The meeting is partially
closed to the public.
Dated: January 20, 2011.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–1673 Filed 1–26–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID: FEMA–2007–0008]
National Advisory Council
Federal Emergency
Management Agency, DHS.
ACTION: Committee Management;
Request for Applicants for Appointment
to the National Advisory Council.
AGENCY:
The Federal Emergency
Management Agency (FEMA) is
requesting individuals who are
interested in serving on the National
Advisory Council (NAC) to apply for
appointment. As provided for in the
Department of Homeland Security
Appropriations Act of 2007, the
Secretary of Homeland Security
established the NAC to ensure effective
and ongoing coordination of Federal
SUMMARY:
E:\FR\FM\27JAN1.SGM
27JAN1
Agencies
[Federal Register Volume 76, Number 18 (Thursday, January 27, 2011)]
[Notices]
[Page 4928]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-1673]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Advisory Council on Drug Abuse, February 2, 2011, 8:30 a.m. to 2:45
p.m., National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD, 20852 which was published in the
Federal Register on January 14, 2011, 76; 10 FR 2011-727.
The time of the closed session on February 2, 2011 was changed to
8:30 a.m. to 10:15 a.m. and the time of the open session was changed to
10:30 a.m. to 2:45 p.m. The meeting is partially closed to the public.
Dated: January 20, 2011.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-1673 Filed 1-26-11; 8:45 am]
BILLING CODE 4140-01-P